The DOI matches its Crossref record; 256 of the 256 references it cites were found in a registry or an index.
Blood-brain barrier regulation in psychiatric disorders
Open accessAbstract
The blood-brain barrier (BBB) is a dynamic interface between the peripheral blood supply and the cerebral parenchyma, controlling the transport of material to and from the brain. Tight junctions between the endothelial cells of the cerebral microvasculature limit the passage of large, negatively charged molecules via paracellular diffusion whereas transcellular transportation across the endothelial cell is controlled by a number of mechanisms including transporter proteins, endocytosis, and diffusion. Here, we review the evidence that perturbation of these processes may underlie the development of psychiatric disorders including schizophrenia, autism spectrum disorder (ASD), and affective disorders. Increased permeability of the BBB appears to be a common factor in these disorders, leading to increased infiltration of peripheral material into the brain culminating in neuroinflammation and oxidative stress. However, although there is no common mechanism underpinning BBB dysfunction even within each particular disorder, the tight junction protein claudin-5 may be a clinically relevant target given that both clinical and pre-clinical research has linked it to schizophrenia, ASD, and depression. Additionally, we discuss the clinical significance of the BBB in diagnosis (genetic markers, dynamic contrast-enhanced-magnetic resonance imaging, and blood biomarkers) and in treatment (drug delivery).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: Pericyte loss influences Alzheimer-like neurodegeneration in mice
Sagare, A. P., Bell, R. D., Zhao, Z., Ma, Q., Winkler, E. A., Ramanathan, A., & Zlokovic, B. V. (2013) · Nature Communications · doi:10.1038/ncomms3932 · Cited by 589
RetractedKessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
Structure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
Pericytes regulate the blood–brain barrier
Armulik, A., Genové, G., Mäe, M., Nisancioglu, M. H., Wallgard, E., Niaudet, C., He, L., Norlin, J., Lindblom, P., Strittmatter, K., et al. (2010) · Nature · doi:10.1038/nature09522 · Cited by 2,843
Multifunctional strands in tight junctions
Tsukita, S., Furuse, M., & Itoh, M. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35067088 · Cited by 2,509
The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
Iadecola, C. (2017) · Neuron · doi:10.1016/j.neuron.2017.07.030 · Cited by 2,480
Pericyte Loss and Microaneurysm Formation in PDGF-B-Deficient Mice
Lindahl, P., Johansson, B. R., Levéen, P., & Betsholtz, C. (1997) · Science · doi:10.1126/science.277.5323.242 · Cited by 2,226
Pericytes are required for blood–brain barrier integrity during embryogenesis
Daneman, R., Zhou, L., Kebede, A. A., & Barres, B. A. (2010) · Nature · doi:10.1038/nature09513 · Cited by 2,128
Blood-brain barrier breakdown in the aging human hippocampus
Montagne, A., Barnes, S. R., Sweeney, M. D., Halliday, M. R., Sagare, A. P., Zhao, Z., Toga, A. W., Jacobs, R. E., Liu, C. Y., Amezcua, L., et al. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.032 · Cited by 2,102
Drug Transport across the Blood–Brain Barrier
Pardridge, W. M. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.126 · Cited by 1,994
Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice
Nitta, T., Hata, M., Gotoh, S., Seo, Y., Sasaki, H., Hashimoto, N., Furuse, M., & Tsukita, S. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302070 · Cited by 1,917
Hellström, M., Kalén, M., Lindahl, P., Abramsson, A., & Betsholtz, C. (1999) · Development · doi:10.1242/dev.126.14.3047 · Cited by 1,700
Establishment and Dysfunction of the Blood-Brain Barrier
Zhao, Z., Nelson, A. R., Betsholtz, C., & Zlokovic, B. V. (2015) · Cell · doi:10.1016/j.cell.2015.10.067 · Cited by 1,670
Adherens and tight junctions: Structure, function and connections to the actin cytoskeleton
Hartsock, A., & Nelson, W. J. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.07.012 · Cited by 1,559
Glial reduction in the subgenual prefrontal cortex in mood disorders
Öngür, D., Drevets, W. C., & Price, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13290 · Cited by 1,525
Rajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y., Overholser, J. C., Roth, B. L., & Stockmeier, C. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00041-4 · Cited by 1,477
Bell, R. D., Winkler, E. A., Sagare, A. P., Singh, I., LaRue, B., Deane, R., & Zlokovic, B. V. (2010) · Neuron · doi:10.1016/j.neuron.2010.09.043 · Cited by 1,448
Fanning, A. S., Jameson, B. J., Jesaitis, L. A., & Anderson, J. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29745 · Cited by 1,432
Kang, D.-W., Adams, J. B., Gregory, A. C., Borody, T., Chittick, L., Fasano, A., Khoruts, A., Geis, E., Maldonado, J., McDonough-Means, S., et al. (2017) · Microbiome · doi:10.1186/s40168-016-0225-7 · Cited by 1,391
Endothelial Cell-to-Cell Junctions: Molecular Organization and Role in Vascular Homeostasis
Bazzoni, G., & Dejana, E. (2004) · Physiological Reviews · doi:10.1152/physrev.00035.2003 · Cited by 1,389
Apolipoprotein E controls cerebrovascular integrity via cyclophilin A
Bell, R. D., Winkler, E. A., Singh, I., Sagare, A. P., Deane, R., Wu, Z., Holtzman, D. M., Betsholtz, C., Armulik, A., Sallstrom, J., et al. (2012) · Nature · doi:10.1038/nature11087 · Cited by 1,293 · cited 1×
“plexes, increasing BBB permeability [263].”
Tight junctions of the blood–brain barrier
Wolburg, H., & Lippoldt, A. (2002) · Vascular Pharmacology · doi:10.1016/s1537-1891(02)00200-8 · Cited by 1,183
Shenton, M. E., Kikinis, R., Jolesz, F. A., Pollak, S. D., LeMay, M., Wible, C. G., Hokama, H., Martin, J., Metcalf, D., Coleman, M., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199208273270905 · Cited by 1,179
Moghaddam, B., & Javitt, D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.181 · Cited by 1,035
Social stress induces neurovascular pathology promoting depression
Menard, C., Pfau, M. L., Hodes, G. E., Kana, V., Wang, V. X., Bouchard, S., Takahashi, A., Flanigan, M. E., Aleyasin, H., LeClair, K. B., et al. (2017) · Nature Neuroscience · doi:10.1038/s41593-017-0010-3 · Cited by 1,028
Self-citationHigh rates of schizophrenia in adults with velo-cardio-facial syndrome
Murphy, K. C., Jones, L. A., & Owen, M. J. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.10.940 · Cited by 1,024
An Overview of Autism Spectrum Disorder, Heterogeneity and Treatment Options
Masi, A., DeMayo, M. M., Glozier, N., & Guastella, A. J. (2017) · Neuroscience Bulletin · doi:10.1007/s12264-017-0100-y · Cited by 987
P-Glycoprotein, a gatekeeper in the blood–brain barrier
Schinkel, A. H. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00085-4 · Cited by 960
Liu, Y., Ho, R. C.-M., & Mak, A. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.08.003 · Cited by 948
Depression as a Microglial Disease
Yirmiya, R., Rimmerman, N., & Reshef, R. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.08.001 · Cited by 944
Basic Neurochemistry: Molecular, Cellular, and Medical Aspects
Davison, A. (1989) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.52.8.1021-a · Cited by 941
Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment
Khandaker, G. M., Cousins, L., Deakin, J., Lennox, B. R., Yolken, R., & Jones, P. B. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)00122-9 · Cited by 926
Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease
Bell, R. D., & Zlokovic, B. V. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0522-3 · Cited by 860
The blood–brain and the blood–cerebrospinal fluid barriers: function and dysfunction
Engelhardt, B., & Sorokin, L. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0177-0 · Cited by 778
Neuroinflammation and psychiatric illness
Najjar, S., Pearlman, D. M., Alper, K., Najjar, A., & Devinsky, O. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-43 · Cited by 733
Circulation and Energy Metabolism of the Brain
Clarke, D. D., & Sokoloff, L. (1999) · Cited by 732
Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall
Lindblom, P., Gerhardt, H., Liebner, S., Abramsson, A., Enge, M., Hellström, M., Bäckström, G., Fredriksson, S., Landegren, U., Nyström, H. C., et al. (2003) · Genes & Development · doi:10.1101/gad.266803 · Cited by 657
Oldendorf, W. H., Cornford, M. E., & Brown, W. J. (1977) · Annals of Neurology · doi:10.1002/ana.410010502 · Cited by 655
Halliday, M. R., Rege, S. V., Ma, Q., Zhao, Z., Miller, C. A., Winkler, E. A., & Zlokovic, B. V. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.44 · Cited by 649
The role of immune dysfunction in the pathophysiology of autism
Onore, C., Careaga, M., & Ashwood, P. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.08.007 · Cited by 635
Cotter, D. (2002) · Cerebral Cortex · doi:10.1093/cercor/12.4.386 · Cited by 634
Sheikov, N., McDannold, N., Vykhodtseva, N., Jolesz, F., & Hynynen, K. (2004) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2004.04.010 · Cited by 617
The dynamic blood–brain barrier
Keaney, J., & Campbell, M. (2015) · The FEBS Journal · doi:10.1111/febs.13412 · Cited by 616
Self-citationAstrocyte Pathology in Major Depressive Disorder: Insights from Human Postmortem Brain Tissue
Rajkowska, G., & Stockmeier, C. (2013) · Current Drug Targets · doi:10.2174/13894501113149990156 · Cited by 603
Glial Loss in the Prefrontal Cortex Is Sufficient to Induce Depressive-like Behaviors
Banasr, M., & Duman, R. S. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.06.008 · Cited by 602
The impact of microglial activation on blood-brain barrier in brain diseases
da Fonseca, A. C. C., Matias, D., Garcia, C., Amaral, R., Geraldo, L. H., Freitas, C., & Lima, F. R. S. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00362 · Cited by 572
Steiner, J., Walter, M., Gos, T., Guillemin, G. J., Bernstein, H.-G., Sarnyai, Z., Mawrin, C., Brisch, R., Bielau, H., zu Schwabedissen, L., et al. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-94 · Cited by 568
The neurovascular unit - concept review
Muoio, V., Persson, P. B., & Sendeski, M. M. (2014) · Acta Physiologica · doi:10.1111/apha.12250 · Cited by 564
Wohleb, E. S., Powell, N. D., Godbout, J. P., & Sheridan, J. F. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1671-13.2013 · Cited by 563
Sengillo, J. D., Winkler, E. A., Walker, C. T., Sullivan, J. S., Johnson, M., & Zlokovic, B. V. (2013) · Brain Pathology · doi:10.1111/bpa.12004 · Cited by 553
Autism spectrum disorder: neuropathology and animal models
Varghese, M., Keshav, N., Jacot-Descombes, S., Warda, T., Wicinski, B., Dickstein, D. L., Harony-Nicolas, H., De Rubeis, S., Drapeau, E., Buxbaum, J. D., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1736-4 · Cited by 536
Capillary K+-sensing initiates retrograde hyperpolarization to increase local cerebral blood flow
Longden, T. A., Dabertrand, F., Koide, M., Gonzales, A. L., Tykocki, N. R., Brayden, J. E., Hill-Eubanks, D., & Nelson, M. T. (2017) · Nature Neuroscience · doi:10.1038/nn.4533 · Cited by 522
Barrier Mechanisms in the Developing Brain
Saunders, N. R., Liddelow, S. A., & Dziegielewska, K. M. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00046 · Cited by 502
Blood–brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders
Fiorentino, M., Sapone, A., Senger, S., Camhi, S. S., Kadzielski, S. M., Buie, T. M., Kelly, D. L., Cascella, N., & Fasano, A. (2016) · Molecular Autism · doi:10.1186/s13229-016-0110-z · Cited by 494
The Gut Microbiota and Autism Spectrum Disorders
Li, Q., Han, Y., Dy, A. B. C., & Hagerman, R. J. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00120 · Cited by 462
Involvement of ROS in BBB dysfunction
Pun, P. B. L., Lu, J., & Moochhala, S. (2009) · Free Radical Research · doi:10.1080/10715760902751902 · Cited by 457
Vita, A., De Peri, L., Deste, G., & Sacchetti, E. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.116 · Cited by 453
Age-associated Physiological and Pathological Changes at the Blood-Brain Barrier: A Review
Erdő, F., Denes, L., & de Lange, E. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16679420 · Cited by 426
Heye, A. K., Culling, R. D., Valdés Hernández, M. D. C., Thrippleton, M. J., & Wardlaw, J. M. (2014) · NeuroImage: Clinical · doi:10.1016/j.nicl.2014.09.002 · Cited by 406
Endothelium-specific platelet-derived growth factor-B ablation mimics diabetic retinopathy
Enge, M. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf418 · Cited by 402
MMP‐9 in translation: from molecule to brain physiology, pathology, and therapy
Vafadari, B., Salamian, A., & Kaczmarek, L. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13415 · Cited by 382
Transport of Glutamate and Other Amino Acids at the Blood-Brain Barrier
Smith, Q. R. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.4.1016s · Cited by 381
Merritt, K., Egerton, A., Kempton, M. J., Taylor, M. J., & McGuire, P. K. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.0442 · Cited by 367 · cited 1×
“A meta-analysis of glutamate levels by magnetic resonance spectroscopy revealed elevations in glutamate and glutamine levels in the basal ganglia and medial temporal lobe [83].”
Impaired Amino Acid Transport at the Blood Brain Barrier Is a Cause of Autism Spectrum Disorder
Tărlungeanu, D. C., Deliu, E., Dotter, C. P., Kara, M., Janiesch, P. C., Scalise, M., Galluccio, M., Tesulov, M., Morelli, E., Sonmez, F. M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.013 · Cited by 367
Insights into Direct Nose to Brain Delivery: Current Status and Future Perspective
Mittal, D., Ali, A., Md, S., Baboota, S., Sahni, J. K., & Ali, J. (2014) · Drug Delivery · doi:10.3109/10717544.2013.838713 · Cited by 359
Domenici, E., Willé, D. R., Tozzi, F., Prokopenko, I., Miller, S., McKeown, A., Brittain, C., Rujescu, D., Giegling, I., Turck, C. W., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009166 · Cited by 347
Argaw, A. T., Zhang, Y., Snyder, B. J., Zhao, M.-L., Kopp, N., Lee, S. C., Raine, C. S., Brosnan, C. F., & John, G. R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.8.5574 · Cited by 339
Ringen, P. A., Engh, J. A., Birkenaes, A. B., Dieset, I., & Andreassen, O. A. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00137 · Cited by 339
Targeted delivery of antibodies through the blood–brain barrier by MRI-guided focused ultrasound
Kinoshita, M., McDannold, N., Jolesz, F. A., & Hynynen, K. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.112 · Cited by 337
Esposito, P., Gheorghe, D., Kandere, K., Pang, X., Connolly, R., Jacobson, S., & Theoharides, T. C. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03026-2 · Cited by 333
Başkaya, M. K., Muralikrishna Rao, A., Doğan, A., Donaldson, D., & Dempsey, R. J. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00239-5 · Cited by 332
Focused ultrasound-mediated drug delivery through the blood–brain barrier
Burgess, A., Shah, K., Hough, O., & Hynynen, K. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1028369 · Cited by 323
Mutations in BCKD-kinase Lead to a Potentially Treatable Form of Autism with Epilepsy
Novarino, G., El-Fishawy, P., Kayserili, H., Meguid, N. A., Scott, E. M., Schroth, J., Silhavy, J. L., Kara, M., Khalil, R. O., Ben-Omran, T., et al. (2012) · Science · doi:10.1126/science.1224631 · Cited by 320 · cited 1×
“Altered amino acid profiles in individuals with autism, epilepsy, and intellectual disability is associated with impaired transport of branch chain amino acids across the BBB [162] and animal models blocking the transcellular transport of branch chain amino acids into the brain results in the development of an ASDlike…”
Cannon, T. D., Thompson, P. M., van Erp, T. G. M., Toga, A. W., Poutanen, V.-P., Huttunen, M., Lonnqvist, J., Standerskjold-Nordenstam, C.-G., Narr, K. L., Khaledy, M., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052023499 · Cited by 314
The blood–brain barrier in psychosis
Pollak, T. A., Drndarski, S., Stone, J. M., David, A. S., McGuire, P., & Abbott, N. J. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30293-6 · Cited by 307
Response of the cerebral vasculature following traumatic brain injury
Salehi, A., Zhang, J. H., & Obenaus, A. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17701460 · Cited by 301
Prakash, R., & Carmichael, S. T. (2015) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000248 · Cited by 296
Holingue, C., Newill, C., Lee, L., Pasricha, P. J., & Daniele Fallin, M. (2018) · Autism Research · doi:10.1002/aur.1854 · Cited by 296 · cited 1×
“This relationship between neurological and gastrointestinal barrier disruption in ASD remains an important area for future research given the high levels of gastrointestinal problems associated with ASD [155] and the proposed interactions between the gut microbiome, inflammation, and neurological symptoms of ASD [156–…”
Luna, R. A., Oezguen, N., Balderas, M., Venkatachalam, A., Runge, J. K., Versalovic, J., Veenstra-VanderWeele, J., Anderson, G. M., Savidge, T., & Williams, K. C. (2017) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2016.11.008 · Cited by 295
Vorbrodt, A. W., & Dobrogowska, D. H. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(03)00177-2 · Cited by 293
Schlageter, K. E., Molnar, P., Lapin, G. D., & Groothuis, D. R. (1999) · Microvascular Research · doi:10.1006/mvre.1999.2188 · Cited by 293
The blood-brain barrier and glutamate
Hawkins, R. A. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27462bb · Cited by 291
Hladky, S. B., & Barrand, M. A. (2016) · Fluids and Barriers of the CNS · doi:10.1186/s12987-016-0040-3 · Cited by 290
Stern, D., Du Yan, S., Fang Yan, S., & Marie Schmidt, A. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00160-6 · Cited by 281
Bauer, B., Hartz, A. M. S., & Miller, D. S. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.029512 · Cited by 275
Autism spectrum disorder in fragile X syndrome: cooccurring conditions and current treatment
Kaufmann, W. E., Kidd, S. A., Andrews, H. F., Budimirovic, D. B., Esler, A., Haas-Givler, B., Stackhouse, T., Riley, C., Peacock, G., Sherman, S. L., et al. (2017) · PEDIATRICS · doi:10.1542/peds.2016-1159f · Cited by 268
Cerebral folate receptor autoantibodies in autism spectrum disorder
Frye, R. E., Sequeira, J. M., Quadros, E. V., James, S. J., & Rossignol, D. A. (2013) · Molecular Psychiatry · doi:10.1038/mp.2011.175 · Cited by 255
Tight junction modulation of the blood brain barrier: CNS delivery of small molecules
Greene, C., & Campbell, M. (2016) · Tissue Barriers · doi:10.1080/21688370.2015.1138017 · Cited by 246
Self-citationMast cells in neuroinflammation and brain disorders
Hendriksen, E., van Bergeijk, D., Oosting, R. S., & Redegeld, F. A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.05.001 · Cited by 241
Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders
Connolly, A. M., Chez, M. G., Pestronk, A., Arnold, S. T., Mehta, S., & Deuel, R. K. (1999) · The Journal of Pediatrics · doi:10.1016/s0022-3476(99)70248-9 · Cited by 236
Bechter, K., Reiber, H., Herzog, S., Fuchs, D., Tumani, H., & Maxeiner, H. G. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.08.008 · Cited by 230
Atopic diseases and inflammation of the brain in the pathogenesis of autism spectrum disorders
Theoharides, T. C., Tsilioni, I., Patel, A. B., & Doyle, R. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.77 · Cited by 230
Metformin ameliorates core deficits in a mouse model of fragile X syndrome
Gantois, I., Khoutorsky, A., Popic, J., Aguilar-Valles, A., Freemantle, E., Cao, R., Sharma, V., Pooters, T., Nagpal, A., Skalecka, A., et al. (2017) · Nature Medicine · doi:10.1038/nm.4335 · Cited by 228
Neurodevelopmental origin of cognitive impairment in schizophrenia
Bora, E. (2015) · Psychological Medicine · doi:10.1017/s0033291714001263 · Cited by 221
Repeated Mild Traumatic Brain Injury: Potential Mechanisms of Damage
Fehily, B., & Fitzgerald, M. (2017) · Cell Transplantation · doi:10.1177/0963689717714092 · Cited by 221
Najjar, S., Pahlajani, S., De Sanctis, V., Stern, J. N. H., Najjar, A., & Chong, D. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00083 · Cited by 221
O'Brien, F. E., Dinan, T. G., Griffin, B. T., & Cryan, J. F. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01557.x · Cited by 215
Morphometric analysis of CNS microvascular endothelium
Coomber, B. L., & Stewart, P. A. (1985) · Microvascular Research · doi:10.1016/0026-2862(85)90042-1 · Cited by 211
Coverage of Blood Vessels by Astrocytic Endfeet Is Reduced in Major Depressive Disorder
Rajkowska, G., Hughes, J., Stockmeier, C. A., Javier Miguel-Hidalgo, J., & Maciag, D. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.09.024 · Cited by 209
Webster, M. J., O’Grady, J., Kleinman, J. E., & Weickert, C. S. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.02.037 · Cited by 208
Glutamate-Mediated Blood-Brain Barrier Opening: Implications for Neuroprotection and Drug Delivery
Vazana, U., Veksler, R., Pell, G. S., Prager, O., Fassler, M., Chassidim, Y., Roth, Y., Shahar, H., Zangen, A., Raccah, R., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0587-16.2016 · Cited by 205
Alzheimer's disease drug development and the problem of the blood‐brain barrier
Pardridge, W. M. (2009) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2009.06.003 · Cited by 203
Gkogkas, C. G., Khoutorsky, A., Cao, R., Jafarnejad, S. M., Prager-Khoutorsky, M., Giannakas, N., Kaminari, A., Fragkouli, A., Nader, K., Price, T. J., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.064 · Cited by 201
Hwang, Y., Kim, J., Shin, J.-Y., Kim, J.-I., Seo, J.-S., Webster, M. J., Lee, D., & Kim, S. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.94 · Cited by 189
Miller, D. H., Thompson, A. J., Morrissey, S. P., MacManus, D. G., Moore, S. G., Kendall, B. E., Moseley, I. F., & McDonald, W. I. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.6.450 · Cited by 188
Anxiety Disorders and Obsessive-Compulsive Disorder in Individuals with Autism Spectrum Disorder
Postorino, V., Kerns, C. M., Vivanti, G., Bradshaw, J., Siracusano, M., & Mazzone, L. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0846-y · Cited by 186
Tight Junctions in Brain Barriers During Central Nervous System Inflammation
Coisne, C., & Engelhardt, B. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.3929 · Cited by 186
Ramaekers, V., Blau, N., Sequeira, J., Nassogne, M.-C., & Quadros, E. (2007) · Neuropediatrics · doi:10.1055/s-2008-1065354 · Cited by 184
Balabanov, R., Washington, R., Wagnerova, J., & Dore-Duffy, P. (1996) · Microvascular Research · doi:10.1006/mvre.1996.0049 · Cited by 182
Webster, M. J., Knable, M. B., Johnston-Wilson, N., Nagata, K., Inagaki, M., & Yolken, R. H. (2001) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2001.0646 · Cited by 179
Van Horn, J. D., & McManus, I. C. (1992) · British Journal of Psychiatry · doi:10.1192/bjp.160.5.687 · Cited by 179
Gosselin, R.-D., Gibney, S., O'Malley, D., Dinan, T. G., & Cryan, J. F. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.10.018 · Cited by 166
Advances in understanding the pathophysiology of autism spectrum disorders
Yenkoyan, K. B., Grigoryan, A., Fereshetyan, K., & Yepremyan, D. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.04.038 · Cited by 166
Autoregulated paracellular clearance of amyloid-β across the blood-brain barrier
Keaney, J., Walsh, D. M., O’Malley, T. T., Hudson, N., Crosbie, D. E., Loftus, T., Sheehan, F., McDaid, J., Humphries, M. M., Callanan, J. J., et al. (2015) · Science Advances · doi:10.1126/sciadv.1500472 · Cited by 164
Self-citationTargeted Nanotechnology in Glioblastoma Multiforme
Glaser, T., Han, I., Wu, L., & Zeng, X. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00166 · Cited by 163
Pathophysiology of status epilepticus
Walker, M. C. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2016.12.044 · Cited by 159
Review: Animal models of acquired epilepsy: insights into mechanisms of human epileptogenesis
Becker, A. J. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12451 · Cited by 159
Increased serum S100B protein in schizophrenia: a study in medication-free patients
Lara, D. R., Gama, C. S., Belmonte-de-Abreu, P., Portela, L. V. C., Gonçalves, C. A., Fonseca, M., Hauck, S., & Souza, D. O. (2001) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(01)00003-6 · Cited by 158
Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF
Rothermundt, M., Falkai, P., Ponath, G. D., Abel, S., Bürkle, H., Diedrich, M., Hetzel, G., Peters, M., Siegmund, A., Pedersen, A., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001548 · Cited by 157
Sidhu, H., Dansie, L. E., Hickmott, P. W., Ethell, D. W., & Ethell, I. M. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1162-14.2014 · Cited by 155 · cited 2×
“Similarly, Fmr1 and Mmp-9 double knock-out mice show less of the ASDlike symptoms than the Fmr1 single knock-out mouse model of Fragile X [176].”
Treatment-resistant depression.
Little, A. A. (2009) · PubMed · Cited by 154
Serum markers support disease-specific glial pathology in major depression
Schroeter, M. L., Abdul-Khaliq, H., Krebs, M., Diefenbacher, A., & Blasig, I. E. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.03.005 · Cited by 152
Mental Depression and Cardiovascular Disease: A Multifaceted, Bidirectional Association
Lippi, G., Montagnana, M., Favaloro, E. J., & Franchini, M. (2009) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0029-1222611 · Cited by 152
Rothermundt, M., Missler, U., Arolt, V., Peters, M. A., Leadbeater, J., Wiesmann, M., Rudolf, S., Wandinger, K.-P., & Kirchner, H. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000889 · Cited by 151
Why is the global CNS pharmaceutical market so under-penetrated?
Pardridge, W. M. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(01)02082-7 · Cited by 148
Liver–brain interactions in inflammatory liver diseases: Implications for fatigue and mood disorders
D’Mello, C., & Swain, M. G. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.10.009 · Cited by 145
Fanning, A. S., Little, B. P., Rahner, C., Utepbergenov, D., Walther, Z., & Anderson, J. M. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-08-0764 · Cited by 144
Sharma, A. N., da Costa e Silva, B. F. B., Soares, J. C., Carvalho, A. F., & Quevedo, J. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.02.067 · Cited by 142
Blood–brain barrier and traumatic brain injury
Alves, J. L. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23300 · Cited by 141
Mast cells, brain inflammation and autism
Theoharides, T. C., Stewart, J. M., Panagiotidou, S., & Melamed, I. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.086 · Cited by 138
Restraint stress-induced morphological changes at the blood-brain barrier in adult rats
Sántha, P., Veszelka, S., Hoyk, Z., Mészáros, M., Walter, F. R., Tóth, A. E., Kiss, L., Kincses, A., Oláh, Z., Seprényi, G., et al. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00088 · Cited by 136
Blood–Brain Barrier Dysfunction as a Hallmark Pathology in Chronic Traumatic Encephalopathy
Doherty, C. P., O’Keefe, E., Wallace, E., Loftus, T., Keaney, J., Kealy, J., Humphries, M. M., Molloy, M. G., Meaney, J. F., Farrell, M., et al. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw036 · Cited by 135
Self-citationWu, J., He, Y., Yang, Z., Guo, C., Luo, Q., Zhou, W., Chen, S., Li, A., Xiong, B., Jiang, T., et al. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2013.10.036 · Cited by 134
Aurrand‐Lions, M., Lamagna, C., Dangerfield, J. P., Wang, S., Herrera, P. L., Nourshargh, S., & Imhof, B. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.6406 · Cited by 133
Brain capillary pericytes contribute to the immune defense in response to cytokines or LPS in vitro
Pieper, C., Marek, J. J., Unterberg, M., Schwerdtle, T., & Galla, H. (2014) · Brain Research · doi:10.1016/j.brainres.2014.01.004 · Cited by 132
Serum S100B Represents a New Biomarker for Mood Disorders
Schroeter, M. L., Sacher, J., Steiner, J., Schoenknecht, P., & Mueller, K. (2013) · Current Drug Targets · doi:10.2174/13894501113149990014 · Cited by 132
Theory of Mind and Schizophrenia: A Positron Emission Tomography Study of Medication-Free Patients
Andreasen, N. C., Calage, C. A., & OʼLeary, D. S. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn034 · Cited by 130
Immune dysregulation in autism spectrum disorder
Noriega, D. B., & Savelkoul, H. F. J. (2013) · European Journal of Pediatrics · doi:10.1007/s00431-013-2183-4 · Cited by 128
Campbell, M., Hanrahan, F., Gobbo, O. L., Kelly, M. E., Kiang, A., Humphries, M. M., Nguyen, A. T. H., Ozaki, E., Keaney, J., Blau, C. W., et al. (2012) · Nature Communications · doi:10.1038/ncomms1852 · Cited by 127
Self-citationSteiner, J., Schiltz, K., Walter, M., Wunderlich, M. T., Keilhoff, G., Brisch, R., Bielau, H., Bernstein, H., Bogerts, B., Schroeter, M. L., et al. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.07.012 · Cited by 126
Mast cell activation and autism
Theoharides, T. C., Angelidou, A., Alysandratos, K.-D., Zhang, B., Asadi, S., Francis, K., Toniato, E., & Kalogeromitros, D. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.017 · Cited by 125
S100B is increased in mood disorders and may be reduced by antidepressive treatment
Schroeter, M. L., Abdul‐Khaliq, H., Diefenbacher, A., & Blasig, I. E. (2002) · Neuroreport · doi:10.1097/00001756-200209160-00021 · Cited by 124
Ultrastructural damage of capillaries in the neocortex in schizophrenia
Uranova, N. A., Zimina, I. S., Vikhreva, O. V., Krukov, N. O., Rachmanova, V. I., & Orlovskaya, D. D. (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622970903414188 · Cited by 123
Nikisch, G., Eap, C. B., & Baumann, P. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.09.010 · Cited by 122
Kumar, H., & Sharma, B. (2015) · Brain Research · doi:10.1016/j.brainres.2015.10.052 · Cited by 119
S100B Serum Levels and Long-Term Improvement of Negative Symptoms in Patients with Schizophrenia
Rothermundt, M., Ponath, G. D., Gläser, T., Hetzel, G., & Arolt, V. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300403 · Cited by 118
The Relationship Between Cerebrospinal Fluid Biomarkers and Depression in Elderly Women
Gudmundsson, P., Skoog, I. G., Wærn, M., Blennow, K., Palsson, S. P., Rosengren, L., & Gustafson, D. (2007) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3180547091 · Cited by 116
The Cerebral Microvasculature in Schizophrenia: A Laser Capture Microdissection Study
Harris, L. W., Wayland, M. T., Lan, M. J., Ryan, M., Giger, T., Lockstone, H. E., Wüthrich, I., Mimmack, M. L., Wang, L., Kotter, M., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003964 · Cited by 114
Breaching the Blood-Brain Barrier as a Gate to Psychiatric Disorder
Shalev, H., Serlin, Y., & Friedman, A. (2009) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2009/278531 · Cited by 113
JAM Family and Related Proteins in Leukocyte Migration (Vestweber Series)
Bradfield, P. F., Nourshargh, S., Aurrand‐Lions, M., & Imhof, B. A. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.147694 · Cited by 113
Neuro-Inflammation, Blood-Brain Barrier, Seizures and Autism
Theoharides, T. C., & Zhang, B. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-168 · Cited by 110
A critical role for VEGF and VEGFR2 in NMDA receptor synaptic function and fear-related behavior
Rossi, P. D., Harde, E., Dupuis, J. P., Martin, L., Chounlamountri, N., Bardin, M., Watrin, C., Benetollo, C., Pernet‐Gallay, K., Luhmann, H. J., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.195 · Cited by 109
Transcriptome alterations of prefrontal cortical parvalbumin neurons in schizophrenia
Enwright III, J. F., Huo, Z., Arion, D., Corradi, J. P., Tseng, G., & Lewis, D. A. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.216 · Cited by 109
Resveratrol suppresses neuroinflammation in the experimental paradigm of autism spectrum disorders
Bhandari, R., & Kuhad, A. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.12.012 · Cited by 106
Memantine ameliorates autistic behavior, biochemistry & blood brain barrier impairments in rats
Kumar, H., & Sharma, B. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.03.013 · Cited by 103
Thomas, A. J., Perry, R. H., Kalaria, R. N., Oakley, A. E., McMeekin, W., & O'Brien, J. T. (2002) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.720 · Cited by 102
Yamamori, H., Hashimoto, R., Ishima, T., Kishi, F., Yasuda, Y., Ohi, K., Fujimoto, M., Umeda-Yano, S., Ito, A., Hashimoto, K., et al. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.09.059 · Cited by 101 · cited 1×
“Two studies reported increased concentrations of MMP-9 and tissue inhibitors of metalloproteinase (TIMP) in schizophrenia [108,109], although another study found no differences between patients and controls from a total of 63 patients with chronic schizophrenia [110].”
Liu, H., Luiten, P. G. M., Eisel, U. L. M., DeJongste, M. J. L., & Schoemaker, R. G. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.02.004 · Cited by 100
Increased hippocampal CA1 cerebral blood volume in schizophrenia
Talati, P., Levendovszky, S. R., Köse, S., Blackford, J. U., Gore, J. C., Donahue, M. J., & Heckers, S. (2014) · NeuroImage Clinical · doi:10.1016/j.nicl.2014.07.004 · Cited by 99
Kinetics of arginine-vasopressin uptake at the blood-brain barrier
Zlokovic, B. V., Hyman, S., McComb, J. G., Lipovac, M. N., Tang, G., & Davson, H. (1990) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(90)90097-8 · Cited by 98
Reduced folate transport to the CNS in female Rett patients
Ramaekers, V. T., Hansen, S. I., Holm, J., Opladen, T., Senderek, J., Häusler, M., Heimann, G., Fowler, B., Maiwald, R., & Blau, N. (2003) · Neurology · doi:10.1212/01.wnl.0000078939.64774.1b · Cited by 98
Agren, H., Reibring, L., Hartvig, P., Tedroff, J., Bjurling, P., Hörnfeldt, K., Andersson, Y., Lundqvist, H., & Långström, B. (1991) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1991.tb05574.x · Cited by 97
Evaluation of cationized rat albumin as a potential blood-brain barrier drug transport vector.
Pardridge, W. M., Triguero, D., Buciak, J. L., & Yang, J. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23180-9 · Cited by 97
Gonçalves, C. A., Leite, M. C., & Guerra, M. C. (2010) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2010/790431 · Cited by 95
Imaging Blood-Brain Barrier Dysfunction in Football Players
Weissberg, I., Veksler, R., Kamintsky, L., Saar‐Ashkenazy, R., Milikovsky, D. Z., Shelef, I., & Friedman, A. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.2682 · Cited by 93
Peripheral vascular endothelial growth factor as a novel depression biomarker: A meta-analysis
Carvalho, A. F., Köhler, C. A., McIntyre, R. S., Knöchel, C., Brunoni, A. R., Thase, M. E., Quevedo, J., Fernandes, B. S., & Berk, M. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.07.002 · Cited by 92
(1984) · PubMed · Cited by 91
Treatment resistant depression
Dave, S., Dogra, N., & Wright, B. (2010) · CRC Press eBooks · doi:10.1201/b13316-61 · Cited by 88
Mu, Q., Johnson, K. A., Morgan, P. S., Grenesko, E. L., Molnar, C., Anderson, B. S., Nahas, Z. H., Kozel, F. A., Köse, S., Knable, M. B., et al. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.03.033 · Cited by 87
Kumar, H., Sharma, B. M., & Sharma, B. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.10.007 · Cited by 86
The CLDN5 locus may be involved in the vulnerability to schizophrenia
Sun, Z.-Y., Wei, J., Xie, L. Y., Shen, Y., Liu, S.-Z., Gao, J., Shi, J., Yu, Y., Zhang, X., Xu, Q., et al. (2004) · European Psychiatry · doi:10.1016/j.eurpsy.2004.06.007 · Cited by 86
Lin, K., Chiu, Y., Tsai, I., Chen, C., Shen, W. W., Liu, S. C., Lu, S., Liu, C.-Y., Hsiao, M., Tang, H., et al. (2010) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32833db216 · Cited by 86
Microvascular anomaly conditions in psychiatric disease. Schizophrenia – angiogenesis connection
Katsel, P., Roussos, P., Pletnikov, M. V., & Haroutunian, V. H. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.04.003 · Cited by 86
Association of serum VEGF levels with prefrontal cortex volume in schizophrenia
Pillai, A., Howell, K. R., Ahmed, A. O., Weinberg, D., Allen, K. M., Bruggemann, J. M., Lenroot, R., Liu, D., Galletly, C. A., Weickert, C. S., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.96 · Cited by 83
Serum S100B is increased during early treatment with antipsychotics and in deficit schizophrenia
Schroeter, M. L. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00383-3 · Cited by 82
Pfister, F., Wang, Y., Schreiter, K., Hagen, F. V., Altvater, K., Hoffmann, S., Deutsch, U., Hammes, H., & Feng, Y. (2009) · Acta Diabetologica · doi:10.1007/s00592-009-0099-2 · Cited by 81
Masopust, J., Malý, R., Andrýs, C., Vališ, M., Bažant, J., & Hosák, L. (2011) · BMC Psychiatry · doi:10.1186/1471-244x-11-2 · Cited by 80
Fujii, T., Ota, M., Hori, H., Sasayama, D., Hattori, K., Teraishi, T., Yamamoto, N., Hashikura, M., Tatsumi, M., Higuchi, T., et al. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.01.012 · Cited by 79
Characterization and Modulation of the Transferrin Receptor on Brain Capillary Endothelial Cells
Visser, C. C., Voorwinden, L. H., Crommelin, D. J. A., Danhof, M., & de Boer, A. G. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000026425.69874.8e · Cited by 79
Nakagawa, Y., & Chiba, K. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.234476 · Cited by 79
de Klerk, O. L., Willemsen, A. T. M., Roosink, M., Bartels, A. L., Hendrikse, N. H., Bosker, F. J., & den Boer, J. A. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709009894 · Cited by 77
Amniotic Fluid MMP ‐9 and Neurotrophins in Autism Spectrum Disorders: An Exploratory Study
Abdallah, M. W., Pearce, B. D., Larsen, N., Greaves‐Lord, K., Nørgaard‐Pedersen, B., HOUGAARD, D. M., Mortensen, E. L., & Grove, J. (2012) · Autism Research · doi:10.1002/aur.1254 · Cited by 76
The Brain-Gut-Microbiome Axis: What Role Does it Play in Autism Spectrum Disorder?
Luna, R. A., Savidge, T., & Williams, K. C. (2016) · Current Developmental Disorders Reports · doi:10.1007/s40474-016-0077-7 · Cited by 76
Yoo, M. H., Kim, T.-Y., Yoon, Y. H., & Koh, J. (2016) · Scientific Reports · doi:10.1038/srep28548 · Cited by 76
Abnormal levels of vascular endothelial biomarkers in schizophrenia
Nguyen, T. T., Dev, S. I., Chen, G., Liou, S. C., Martin, A. S., Irwin, M. R., Carroll, J., Tu, X. M., Jeste, D. V., & Eyler, L. T. (2017) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-017-0842-6 · Cited by 76
Azmitia, E. C., Saccomano, Z. T., Alzoobaee, M. F., Boldrini, M., & Whitaker‐Azmitia, P. M. (2015) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-015-2672-6 · Cited by 75
Decreased VEGF mRNA expression in the dorsolateral prefrontal cortex of schizophrenia subjects
Fulzele, S., & Pillai, A. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.06.005 · Cited by 73
Frye, R. E., Delhey, L. M., Slattery, J. M., Tippett, M., Wynne, R. A., Rose, S., Kahler, S. G., Bennuri, S. C., Melnyk, S., Sequeira, J. M., et al. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00080 · Cited by 73
Li, Q. S., Tian, C., Seabrook, G. R., Drevets, W. C., & Narayan, V. A. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.171 · Cited by 72
AL-Ayadhi, L. Y., & Mostafa, G. A. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-54 · Cited by 71
Transcriptome sequencing of the choroid plexus in schizophrenia
Kim, S., Hwang, Y., Lee, D., & Webster, M. J. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.229 · Cited by 70
Schroeter, M. L., Steiner, J., & Mueller, K. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.11.008 · Cited by 68
Winkler, M. K. L., Chassidim, Y., Lublinsky, S., Revankar, G. S., Major, S., Kang, E., Oliveira-Ferreira, A. I., Woitzik, J., Sandow, N., Scheel, M., et al. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03699.x · Cited by 68
Niitsu, T., Ishima, T., Yoshida, T., Hashimoto, T., Matsuzawa, D., Shirayama, Y., Nakazato, M., Shimizu, E., Hashimoto, K., & Iyo, M. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.12.009 · Cited by 67
The clinical application of ABCB1 genotyping in antidepressant treatment: a pilot study
Breitenstein, B., Scheuer, S., Pfister, H., Uhr, M., Lucae, S., Holsboer, F., Ising, M., & Brückl, T. M. (2013) · CNS Spectrums · doi:10.1017/s1092852913000436 · Cited by 67
ABCB1 gene variants and antidepressant treatment outcome: A meta‐analysis
Breitenstein, B., Brückl, T. M., Ising, M., Müller‐Myhsok, B., Holsboer, F., & Czamara, D. (2015) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32309 · Cited by 66
Blecharz, K., Haghikia, A., Stasiołek, M., Kruse, N., Drenckhahn, D., Gold, R., Roewer, N., Chan, A., & Förster, C. Y. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458509358189 · Cited by 66
Onore, C. E., Nordahl, C. W., Young, G. S., de Water, J. V., Rogers, S. J., & Ashwood, P. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.05.004 · Cited by 65
Cited by
Claudin-5: gatekeeper of neurological function
Greene, C., Hanley, N., & Campbell, M. (2019) · Fluids and Barriers of the CNS · doi:10.1186/s12987-019-0123-z · Cited by 583
Self-citationXiong, B., Wang, Y., Chen, Y., Xing, S., Liao, Q., Chen, Y., Li, Q., Li, W., & Sun, H. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00910 · Cited by 232
The Gut–Brain–Microbiota Connection and Its Role in Autism Spectrum Disorders
Młynarska, E., Barszcz, E., Budny, E., Gajewska, A., Kopeć, K., Wasiak, J., Rysz, J., & Franczyk, B. (2025) · Nutrients · doi:10.3390/nu17071135 · Cited by 44
Wasiak, J., & Gawlik-Kotelnicka, O. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114459 · Cited by 47
Kim, J., Um, H., Kim, N. H., & Kim, D. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.01.006 · Cited by 33
Metadata
- Authors
- Kealy, J., Greene, C., & Campbell, M.
- Venue
- Neuroscience Letters
- Publisher
- Elsevier BV
- Published
- 2020-05
- Volume
- 726
- Pages
- 133664
- ISSN
- 0304-3940 (ISSN-L)
- OpenAlex
- W2810906666
- Cited by
- 307
- References
- 256
- FWCI
- 8.64
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.